Characteristics and outcome of patients with primary CNS lymphoma in a “real-life” setting compared to a clinical trial
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00277-016-2602-5.pdf
Reference30 articles.
1. Rubenstein J, Ferreri AJ, Pittaluga S (2008) Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment. Leuk Lymphoma 49(Suppl 1):43–51
2. Villano JL, Koshy M, Shaikh H, Dolecek TA, McCarthy BJ (2011) Age, gender, and racial differences in incidence and survival in primary CNS lymphoma. Br J Cancer 105:1414–1418
3. Phillips EH, Fox CP, Cwynarski K (2014) Primary CNS lymphoma. Curr Hematol Malig Rep 9:243–253
4. Korfel A, Thiel E, Martus P et al (2015) Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma. Neurology 84:1242–1248
5. Batchelor T, Carson K, O’Neill A et al (2003) Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07. J Clin Oncol 21:1044–1049
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The importance of comparing controlled clinical trials to treatment implementation in the clinical setting;Injury;2023-11
2. First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study;BMC Cancer;2023-08-11
3. Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas;Journal of Clinical Oncology;2023-03-20
4. Long‐term outcomes of frontline intensification in primary CNS lymphoma: A real‐world single‐center experience;Cancer Medicine;2023-01-17
5. The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?;Radiation Oncology;2022-10-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3